<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01985854</url>
  </required_header>
  <id_info>
    <org_study_id>TIVA DES conversion</org_study_id>
    <nct_id>NCT01985854</nct_id>
  </id_info>
  <brief_title>Conversion From Total Intravenous Anesthesia Technique to Desflurane Anesthesia for Long Duration Neurosurgery</brief_title>
  <official_title>Conversion From Total Intravenous Anesthesia Technique to Desflurane Anesthesia for Long Duration Neurosurgery: A Pilot Study for Assessment of Recovery Parameters</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tokyo Women's Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Baxter Healthcare Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Tokyo Women's Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Since neurological testing during neurosurgery, such as somato-sensory evoked potentials,
      motor-evoked potentials, auditory evoked potentials and visual evoked potentials are well
      maintained their wave-form reactivity with total intravenous anaesthesia technique better
      than inhalational anesthetic techniques, the standard anesthesia method for neurosurgery is
      usually total intravenous anaesthesia technique. Nonetheless, after finishing recording the
      evoked potential responses during surgery, facilitation of recovery from general anesthesia
      is getting important, because the real neurological physical examination is much more
      sensitive than above electrical evoked potentials to evaluate the results of surgical
      operation.

      We propose to evaluate the recovery parameters after conversion from total intravenous
      anaesthesia technique to Desflurane anesthesia during long term neurosurgery procedures. The
      conversion will be initiated upon completion of the neurophysiological electric evoked
      potentials assessment. Based on the pharmacological properties of desflurane, we hypothesize
      that recovery after conversion to Desflurane will be faster compared to recovery after total
      intravenous anaesthesia alone.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>January 2014</start_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time from the discontinuation of anesthesia to extubation</measure>
    <time_frame>Patients will be followed in the operation room, an expected average of 30 minutes.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time from the discontinuation of anesthesia to eye opening</measure>
    <time_frame>At the end of surgery, duration time from the discontinuation of anesthesia to the eye opening will be measured, averaged expected time is 30 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive function</measure>
    <time_frame>Up to 24 hours</time_frame>
    <description>Cognitive function will be measured by Mini-Mental state examination at baseline (preoperatively) 5 minutes and 24 hours after extubation. Postoperative recovery function will be also measured by Post-operative Quality Recovery Scale (PQRS scale) at 5 minutes and 24 hours after extubation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time from the discontinuation of anesthesia to orientation</measure>
    <time_frame>Up to 24 hours</time_frame>
    <description>Time from the discontinuation of anesthesia to orientation (State name, state the date of birth)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Length of ICU stay</measure>
    <time_frame>Patients will be followed for the duration of intensive care unit stay, an expected average of 1 week</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Patients Undergoing Elective Craniotomy</condition>
  <arm_group>
    <arm_group_label>Propofol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Propofol target-controlled infusion will be kept 2-4μg /ml plasma concentration throughout procedure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Desflurane</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>After taking off the electrophysiological monitoring from the patients, discontinue propofol and start desflurane from 6% (dialed concentration) at flow rate of 4L/min for 2 minutes in desflurane group. When achieve end tidal concentration of 4-5%, decrease the flow rate to 2L/min.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <arm_group_label>Propofol</arm_group_label>
    <other_name>Diprivan</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Desflurane</intervention_name>
    <arm_group_label>Desflurane</arm_group_label>
    <other_name>Suprane</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing elective craniotomy

          -  American Society of Anesthesiology Physical Status Ⅰ, II and III

          -  Age: between 20 to 65 years

          -  Sex: male or female

          -  Patients who are postmenopausal or surgically sterilized

          -  Expected Operation time is longer than 4 hours.

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Makoto Ozaki, Ph.D</last_name>
    <role>Study Chair</role>
    <affiliation>Tokyo Women's Mecical University, Department of Anesthesiology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Makoto Ozaki, Ph.D</last_name>
    <phone>81-3-3353-8111</phone>
    <phone_ext>28290</phone_ext>
    <email>mozaki@anes.twmu.ac.jp</email>
  </overall_contact>
  <location>
    <facility>
      <name>Tokyo Women's Medical University Hospital</name>
      <address>
        <city>Tokyo</city>
        <zip>1628666</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Makoto Ozaki, Ph.D</last_name>
      <phone>81-3-3353-8111</phone>
      <phone_ext>28290</phone_ext>
      <email>mozaki@anes.twmu.ac.jp</email>
    </contact>
    <contact_backup>
      <last_name>Kasuya Yusuke, Ph.D</last_name>
      <phone>81-3-3353-8111</phone>
      <phone_ext>29472</phone_ext>
      <email>kasuyay@mb.infoweb.ne.jp</email>
    </contact_backup>
    <investigator>
      <last_name>Makoto Ozaki, M.D, Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yusuke Kasuya, M.D, Ph.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nobutada Morioka, M.D, Ph.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shunichi Takagi, M.D, Ph.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maho Kinoshita, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mirei Nagai, M.D, Ph.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yoshikazu Okada, M.D, Ph.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 7, 2013</study_first_submitted>
  <study_first_submitted_qc>November 9, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 15, 2013</study_first_posted>
  <last_update_submitted>November 9, 2013</last_update_submitted>
  <last_update_submitted_qc>November 9, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 15, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tokyo Women's Medical University</investigator_affiliation>
    <investigator_full_name>Makoto Ozaki</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Desflurane</keyword>
  <keyword>Propofol</keyword>
  <keyword>Total intravenous anesthesia</keyword>
  <keyword>Neurosurgery</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Desflurane</mesh_term>
    <mesh_term>Isoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

